Bizmoon
Grants & Loans
Regulations
Industries
Sign in
Learn more
Bizmoon

Product

  • Grants
  • Regulations
  • License checker
  • Guides
  • How it works
  • Pricing
  • Blog

Industries

  • Healthcare
  • Trade and Commerce
  • Transportation and Logistics
  • Energy and Utilities
  • Finance and Banking
  • Land and Natural Resources
  • Agriculture

Coverage

  • All grants
  • All regulations
  • Federal grants
  • Federal regulations

Company

  • Careers
  • Sign in
© 2026 BizmoonPrivacyTermsCredits
  1. Home
  2. Regulations
  3. Federal

Federal regulations

Agency
  • SEC229
  • HHS221
  • DOC218
  • DOT
211
  • FDA194
  • DOE160
  • DHS154
  • FERC142
  • FAA111
  • EPA92
  • DOJ73
  • NOAA68
  • USDA65
  • Treasury64
  • NIH56
  • DOL47
  • FCC29
  • SBA29
  • HUD22
  • CMS18
  • IRS16
  • FTC4
  • Topic
    • Compliance5
    • Product3
    • Finance2
    • Operations2
    • Product Development2
    • Tax2
    • Business Development1
    • Sales1
    Recency
    • Last 30 days
    • Last 7 days
    CMSRemove filter: CMSDOLRemove filter: DOLFDARemove filter: FDAIRSRemove filter: IRSNIHRemove filter: NIHUSDARemove filter: USDAClear all
    • Information Collection Request; General Program Administration
      July 6, 2026

      Farm Service Agency seeks public comments on a revised information collection for General Program Administration to verify applicant eligibility, authorized loan use, and government security interests under the Paperwork Reduction Act.

    • Agency Information Collection Activities; Proposed Collection; Comment Request; Biologics License Applications, Procedures and Requirements
      July 6, 2026

      FDA seeks 60 days of public comment on information collection requirements for Biologics License Applications under the Paperwork Reduction Act; deadline for comments is 60 days from Federal Register publication.

    • Determination That VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, Injection, 50 units/50 milliliters (1 unit/milliliters) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
    Page 1 of 40 (396 total)Next

    Track Federal regulations for your business

    Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.

    Action items + deadlines

    Every rule is broken into specific to-dos with calendar dates.

    Affected areas

    We tell you which parts of your business each rule actually touches.

    Plain-English summaries

    Healthcare draws more federal rulemaking than any other sector

    After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.

    Federal rulemaking

    • Healthcare and life sciences
    • Trade and commerce
    • Transportation and aviation
    • Energy and utilities
    • Finance
    • Natural resources
    • Other

    Browse by agency

    • CMS
    • DHS
    • DOC
    • DOE
    • DOJ
    • DOL

    Browse by state

    • Arizona
    • California
    • Colorado
    • Florida
    • Illinois
    • Kentucky
    July 6, 2026

    FDA determines that vasopressin 0.9% injection was not withdrawn for safety or effectiveness reasons, allowing approval of generic abbreviated new drug applications if other regulatory requirements are met.

  • Submission for OMB Review; Comment Request
    July 6, 2026

    I need the description to create an accurate summary. Please provide the description field for this OMB submission document.

  • Submission for OMB Review; Comment Request
    July 6, 2026

    OMB review process for federal regulations requires public comment submissions; the comment period deadline and specific regulatory details are not specified in the title alone.

  • Privacy Act of 1974; Matching Program
    July 6, 2026

    Centers for Medicare & Medicaid Services launches a matching program with the Department of Veterans Affairs to verify eligibility for insurance affordability programs under the Affordable Care Act.

  • Expedited Investigational New Drug Pilot Program; Request for Information; Correction
    July 6, 2026

    FDA corrects contact information for the Expedited Investigational New Drug Pilot Program docket, which solicits public input on shortening timelines from drug identification to first-in-human clinical trials.

  • Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Approval of Medical Devices
    July 6, 2026

    The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.

  • Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
    July 6, 2026

    FDA withdraws approval of 34 new drug applications across multiple applicants whose manufacturers requested withdrawal due to discontinued marketing.

  • Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Administrative Practices and Procedures; Formal Hearings
    July 6, 2026

    FDA submitted a proposed information collection to OMB for Paperwork Reduction Act review regarding formal hearing administrative procedures and practices.

  • No legal jargon. Read the impact in two sentences.

    Real-time alerts

    Email + dashboard pings the moment something changes.

    Get started free
  • DOT
  • EPA
  • FAA
  • FCC
  • FDA
  • FERC
  • FTC
  • HHS
  • HUD
  • IRS
  • NIH
  • NOAA
  • SBA
  • SEC
  • Treasury
  • USDA
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Missouri
  • New York
  • North Carolina
  • Ohio
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Texas
  • Virginia
  • Washington
  • Wisconsin
  • Federal grants